Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Greenbrook Tms ( (GBNHF) ) has provided an update.
Greenbrook TMS Inc. has entered into unsecured promissory notes with Madryn Health Partners, borrowing $1.5 million for general corporate purposes. Additionally, Greenbrook completed a significant restructuring whereby Neuronetics, Inc. acquired all Greenbrook’s common shares. This acquisition included a conversion of Greenbrook’s outstanding debt into shares, leading to Madryn becoming the largest shareholder before the shares were exchanged with Neuronetics. The transaction marks a transformative moment in mental health therapy delivery, combining Neuronetics’ technology with Greenbrook’s treatment network, enhancing market position and operational synergies.
More about Greenbrook Tms
YTD Price Performance: -94.44%
Average Trading Volume: 38,490
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $2.53M
See more insights into GBNHF stock on TipRanks’ Stock Analysis page.
